Lixte Biotechnology Holdings Inc. (LIXT)
Market Closed
3 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
6. 7100
-0.33
-4.69%
$
79.5M Market Cap
- P/E Ratio
- Div Yield
244,181 Volume
0 Eps
$ 7.04
Previous Close Investors:
Want to track LIXT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
Accesswire | 1 year ago
